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Total joint replacement (TJR) surgery was a milestone in 
rheumatology. Patients whose inﬂ  ammatory joint disease 
once conﬁ  ned them to a wheelchair or bed received a 
new joint and were able to walk. But 50  years later, 
approaches have changed. A current trend, as reported 
by Hekmat and colleagues [1] in a recent issue of Arthritis 
Research & Th  erapy, is to gather evidence that TJR is not 
needed for patients with rheumatoid arthritis (RA) as 
inﬂ  ammation and consequent damage can be kept under 
control with improved medications.
A need for a TJR of the hip or knee has been a severe 
long-term consequence for patients with RA. Wolfe and 
Zwillich [2] estimated that 25% of all RA patients who 
were under observation between the 1970s and 1990s 
needed TJR surgery over two decades.
Concomitantly with an increasing use of early and 
active treatment strategies, the clinical status of patients 
with RA has improved in comparison with previous 
decades. Even before the era of biologic treatments, 
improve  ments were seen in patients’ clinical status as 
measured by disease activity, functional capacity, radio-
graphic scores, and other clinical parameters [3]. 
Further  more, lower mortality rates were reported in 
patients who responded to methotrexate and lower work 
disability rates were noted in patients who responded to 
anti-rheumatic drugs [4].
Although improvements were seen in clinical out-
comes, it was a long time before studies showed changes 
in the rates of TJR. Only in the last 10 years have studies 
from Western countries and Japan suggested that rates of 
TJR and other RA-related surgeries have been stable or 
decreased in patients with RA [5-13], as now reported 
also by Hekmat and colleagues [1]. Declining trends of 
TJR surgeries in patients with RA contrasts with a 
remarkable phenomenon of the increase in overall rates 
of TJR surgery of the knee or hip documented in the 
general population of many countries having doubled 
since 1990, and increased threefold since the early 1980s 
[5,14,15].
Hekmat and colleagues [1] identiﬁ  ed prevalent cases 
with RA in 1997 and incident cases from 1997 to 2007 in 
a community-based register in Malmö, Sweden, and 
linked them to the Swedish hip and knee arthroplasty 
registers. Th  e incidence of a primary TJR of the hip or 
knee in 1998-2001 (before tumor necrosis factor inhi-
bitors were available for the treatment of RA) was 
compared with that in 2002-2006/07 (after these inhibi-
tors became available). A decline was seen in the 
incidence of the primary hip TJR from 12.6 to 6.6 per 
1,000 person-years, whereas a slight trend toward an 
increase of primary TJR of the knee was observed.
What does this study teach us? First, this study provides 
further evidence of improving outcomes of RA. TJR of 
the hip or knee is a severe long-term outcome for patients 
with RA and accounts for a substantial component of the 
costs of this disease [16]. Overall rates of TJR surgery of 
the hip or knee in general population have been 
documented to have been doubled since 1990 and 
increased threefold since the early 1980s in many 
countries. Th  ese ﬁ   ndings indicate an increased need, 
associated with aging of the population, for TJR surgery 
in the population and apparently availability of greater 
resources to perform these procedures. Th  erefore, if 
patients with RA would need TJR surgeries, resources 
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© 2011 BioMed Central Ltdwould be available in many countries. Second, this study, 
like many other Swedish and Scandinavian studies [17], is 
an excellent example of the value of national registers and 
their use in epidemiological research. Th  e observations 
by Hekmat and colleagues [1] emphasize the beneﬁ  ts of 
active treatment strategies for patients with RA. 
Advances in RA would allow future availability of 
resources for TJR surgery for the increasing number of 
people with osteoarthritis in aging popu  la  tions. Finally, 
Hekmat and colleagues [1] report promis  ing observations 
from a developed country with a long history of national 
registers and availability of biologic treatments for RA. 
We must recognize that many societies are not as 
fortunate. Worldwide, many patients with RA, perhaps 
the majority of them, still suﬀ  er from severe RA [18], and 
measures are needed to improve outcomes of all patients 
with RA in all countries.
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